Patents
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
09/2010
09/01/2010CN101821226A Leukotriene b4 inhibitors
08/2010
08/31/2010US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example
08/31/2010US7786121 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals
08/31/2010US7786115 Amide derivatives
08/26/2010WO2010095142A2 Novel polymorphs of saquinavir
08/26/2010WO2010095106A1 Solid forms of ( 2r) -2- { ( is ) -6, 7 -dimethoxy- 1- [2- (4-triflu0r0methyl-phenyl) -ethyl] -3, 4-dihydr0-1h -isoquinolin-2-yl} -n-methyl-2-phenyl-acetamide hydrochloride
08/26/2010US20100217003 1,2,3,4-tetrahydroisoquinoline derivatives having effects of preventing and treating degenerative and inflammatory diseases
08/25/2010EP1551834B1 Substituted quinazolinone compounds
08/25/2010CN101812018A Stable Moexipril metal salt and preparation method thereof
08/24/2010US7781461 Neuropeptide Y receptor antagonists comprising 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide and a pharmaceutically acceptable carrier, used for the treatment of obesity and as anorexigenic agents
08/24/2010US7781457 Isoquinolinone potassium channel inhibitors
08/24/2010CA2459752C 3-aminocarbonyl-substituted benzoylcyclohexanediones which can be used as herbicides
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
08/19/2010WO2010039534A3 Viral and fungal inhibitors
08/18/2010EP2217572A1 Isoquinoline modulators of atp-binding cassette transporters
08/18/2010CN101808992A 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
08/18/2010CN101805266A Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/17/2010US7776919 modulators of the interaction between the receptor for advanced glycated end products; 3-(4-Benzyloxyphenyl)propionic Acid 2,4- Di-(3-Diethylamino-1-propoxy)aniline Amide; acute and chronic inflammation; diabetic late complications; Alzheimer's disease, erectile dysfunction; metastasis
08/17/2010US7776874 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
08/12/2010WO2010090304A1 Acylguanidine derivative
08/05/2010WO2010088414A2 Subunit selective nmda receptor potentiators for the treatment of neurological conditions
08/05/2010US20100197725 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
08/05/2010US20100197706 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics
08/05/2010US20100197688 Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
08/05/2010US20100197664 Novel b1-antagonists
08/04/2010EP2212277A1 Amine linked modulators of y-secretase
08/04/2010EP1667976B1 Isoquinolinone potassium channel inhibitors
08/04/2010CN101792422A Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/03/2010US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators
07/2010
07/29/2010WO2010085525A1 Bridged and fused heterocyclic antidiabetic compounds
07/29/2010US20100190801 Triazolopyridine derivatives as inhibitors of lipases and phospholipases
07/29/2010US20100187978 Material for organic electro-optical device having fluorene derivative compound and organic electro-optical device including the same
07/28/2010CN101790518A Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics
07/28/2010CN101790514A 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
07/28/2010CN101786984A Method for extracting liensinine, isoliensinine and neferine from lotus plumule
07/28/2010CN101786983A Method for preparing 2-amino-1,2-dihydro-isoquinoline compound
07/27/2010US7763638 Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
07/27/2010US7763614 Isoquinoline potassium channel inhibitors
07/22/2010WO2010082563A1 Cyclic compound having hetero atom
07/22/2010WO2010011853A3 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
07/22/2010US20100184988 Process for producing cisatracurium compounds and associated intermediates
07/22/2010US20100184802 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof
07/22/2010US20100184768 Isoprenyl Compounds and Methods Thereof
07/22/2010CA2749114A1 Heteroatom-containing cyclic compound
07/21/2010EP2208727A1 Diaryl ethers as opioid receptor antagonist
07/21/2010EP1893573B1 Inhibitors of hcv replication
07/21/2010CN101781247A New method for synthesizing substituted 3-quinoline carboxylic acid and analogue
07/20/2010US7759388 Phenylalanine derivatives
07/20/2010US7759344 Bis-aryl amide derivatives and methods of use
07/20/2010CA2407866C Process for the synthesis of amine ethers from secondary amino oxides
07/20/2010CA2399001C Integrin expression inhibitor
07/15/2010WO2010080398A1 Sulfonamides as trpm8 modulators
07/15/2010WO2010057101A3 Compounds useful as hiv blockers
07/15/2010US20100179153 Bicyclic S1P Receptor Modulators
07/15/2010US20100179140 Indenoisoquinolinone analogs and methods of use thereof
07/15/2010US20100179119 Inhibitors of Integrin Alpha2Beta1 Based on Prolyl Diaminopropionic Acid Scaffold
07/15/2010CA2747662A1 Sulfonamides as trpm8 modulators
07/14/2010EP2205562A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
07/14/2010EP2205559A1 Renin inhibitors
07/13/2010US7754884 Targeted, NIR imaging agents for therapy efficacy monitoring, deep tissue disease demarcation and deep tissue imaging
07/13/2010CA2539546C Isoquinoline potassium channel inhibitors
07/08/2010WO2010078449A2 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
07/08/2010WO2010075973A1 Substituted 4-(1,2,3,4-tetrahydroisochinolin-2-yl)-4-oxo-butyric acid amide as kcnq2/2 modulators
07/08/2010WO2010055164A3 Isoquinolone derivatives as inhibitors of plavivirus replication
07/08/2010US20100173886 Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders
07/08/2010CA2748607A1 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
07/08/2010CA2747094A1 Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as kcnq2/3 modulators
07/07/2010EP1485099B1 Inhibitors of histone deacetylase
07/07/2010CN101768115A Preparation method of N-[11C] methyl-N-(1-methyl propyl)-1-(2-chlorphenyl) isoquinoline-3-carbamoyl
07/06/2010CA2539814C Isoquinolinone potassium channel inhibitors
07/06/2010CA2539479C Isoquinoline potassium channel inhibitors
07/01/2010WO2010074272A1 Method for rapidly methylating heteroaromatic ring aryl and method for producing pet tracer
07/01/2010WO2010074244A1 Isoquinoline derivative
07/01/2010WO2010037050A3 Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
07/01/2010US20100168431 Novel isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
07/01/2010US20100168160 Genipin Derivatives and Uses Thereof
07/01/2010US20100168154 1-substituted tetrahydroisoquinoline compound
07/01/2010US20100166765 Benzoquinazoline derivatives
07/01/2010CA2747795A1 Isoquinoline derivative
06/2010
06/30/2010EP2200989A1 Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists
06/30/2010EP2200987A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
06/30/2010CN101759637A N-aryl-3,4-dihydro-isoquinoline salt and application thereof in preparing acaricidal and antibiotic medicament
06/30/2010CN101759636A Fine purification method of isoquinoline
06/29/2010US7745465 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease
06/29/2010US7745460 LFA1 related immune and/or inflammatory disorders; interactions with leukointegrins; such as fused nitrogen heterocyclic secondary amine derivatives
06/29/2010CA2539541C Isoquinolinone potassium channel inhibitors
06/24/2010WO2010071117A1 Method for manufacturing (s)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
06/24/2010US20100160289 Sulfonamides as trpm8 modulators
06/23/2010EP2199285A1 Processes for preparing morphinans and intermediates thereof
06/23/2010EP2197848A1 Novel r,r'-atracurium salts
06/23/2010CN101747271A Method for preparing polysubstituted isoquinoline compounds
06/23/2010CN101747270A Method for preparing isoquinoline-containing ylide analogue
06/23/2010CN101747269A Purification method of isoquinoline
06/23/2010CN101747262A Electron transporting-injection material and organic electroluminescent device using the same
06/22/2010US7741322 Isoquinolinone potassium channel inhibitors
06/22/2010US7741316 Pharmacological uses of azetidine derivatives
06/17/2010US20100152251 Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
06/17/2010US20100152237 Bis-pyrindino containing compounds for the use in the treatment of cns pathologies
06/17/2010US20100152234 Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators
06/17/2010US20100152138 Cyclic amine bace-1 inhibitors having a benzamide substituent
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 119